The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Standard Lancets Market Research Report 2025

Global Standard Lancets Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1608783

No of Pages : 111

Ask Your Query
Synopsis
Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.
The global Standard Lancets market was valued at US$ 1456.2 million in 2023 and is anticipated to reach US$ 1995 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
The Standard Lancets market is a fundamental component of the broader medical and healthcare industry, focusing on the production and distribution of lancets used in blood glucose monitoring. These tiny, disposable devices are designed for the quick and nearly painless pricking of the skin to obtain a small blood sample for glucose testing, a critical routine for millions of individuals with diabetes. Standard lancets are widely utilized by patients, healthcare professionals, and individuals monitoring their blood sugar levels at home. They come in a variety of gauges to accommodate different skin types and pain sensitivities. The market is characterized by its commitment to ensuring safe and hygienic lancet products, which are critical to reducing the risk of infection and promoting effective self-monitoring. Leading manufacturers and brands, including BD, Accu-Chek, and OneTouch, provide a wide range of standard lancets to cater to the diverse needs of the diabetic population. As diabetes management continues to be a global health concern, the Standard Lancets market remains indispensable, offering the tools necessary to support the health and well-being of individuals living with diabetes.
This report aims to provide a comprehensive presentation of the global market for Standard Lancets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Standard Lancets.
Report Scope
The Standard Lancets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Standard Lancets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Standard Lancets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Lifescan
BD
Bayer
Abbott
B. Braun
ARKRAY
Terumo
I-SENS
Nipro
Omron
Infopia
AgaMatrix
Smiths Medical
Sarstedt
SANNUO
Yicheng
Yuwell
Greiner Bio One
Edan
Narang Medical
Accu-Chek
OneTouch
Segment by Type
Safety Lancet
Ordinary Lancet
Segment by Application
Cholesterol Tests
Glucose Tests
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Standard Lancets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Standard Lancets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Standard Lancets Market Overview
1.1 Product Overview and Scope of Standard Lancets
1.2 Standard Lancets Segment by Type
1.2.1 Global Standard Lancets Market Value Comparison by Type (2024-2030)
1.2.2 Safety Lancet
1.2.3 Ordinary Lancet
1.3 Standard Lancets Segment by Application
1.3.1 Global Standard Lancets Market Value by Application: (2024-2030)
1.3.2 Cholesterol Tests
1.3.3 Glucose Tests
1.3.4 Others
1.4 Global Standard Lancets Market Size Estimates and Forecasts
1.4.1 Global Standard Lancets Revenue 2019-2030
1.4.2 Global Standard Lancets Sales 2019-2030
1.4.3 Global Standard Lancets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Standard Lancets Market Competition by Manufacturers
2.1 Global Standard Lancets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Standard Lancets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Standard Lancets Average Price by Manufacturers (2019-2024)
2.4 Global Standard Lancets Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Standard Lancets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Standard Lancets, Product Type & Application
2.7 Standard Lancets Market Competitive Situation and Trends
2.7.1 Standard Lancets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Standard Lancets Players Market Share by Revenue
2.7.3 Global Standard Lancets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Standard Lancets Retrospective Market Scenario by Region
3.1 Global Standard Lancets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Standard Lancets Global Standard Lancets Sales by Region: 2019-2030
3.2.1 Global Standard Lancets Sales by Region: 2019-2024
3.2.2 Global Standard Lancets Sales by Region: 2025-2030
3.3 Global Standard Lancets Global Standard Lancets Revenue by Region: 2019-2030
3.3.1 Global Standard Lancets Revenue by Region: 2019-2024
3.3.2 Global Standard Lancets Revenue by Region: 2025-2030
3.4 North America Standard Lancets Market Facts & Figures by Country
3.4.1 North America Standard Lancets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Standard Lancets Sales by Country (2019-2030)
3.4.3 North America Standard Lancets Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Standard Lancets Market Facts & Figures by Country
3.5.1 Europe Standard Lancets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Standard Lancets Sales by Country (2019-2030)
3.5.3 Europe Standard Lancets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Standard Lancets Market Facts & Figures by Country
3.6.1 Asia Pacific Standard Lancets Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Standard Lancets Sales by Country (2019-2030)
3.6.3 Asia Pacific Standard Lancets Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Standard Lancets Market Facts & Figures by Country
3.7.1 Latin America Standard Lancets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Standard Lancets Sales by Country (2019-2030)
3.7.3 Latin America Standard Lancets Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Standard Lancets Market Facts & Figures by Country
3.8.1 Middle East and Africa Standard Lancets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Standard Lancets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Standard Lancets Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Standard Lancets Sales by Type (2019-2030)
4.1.1 Global Standard Lancets Sales by Type (2019-2024)
4.1.2 Global Standard Lancets Sales by Type (2025-2030)
4.1.3 Global Standard Lancets Sales Market Share by Type (2019-2030)
4.2 Global Standard Lancets Revenue by Type (2019-2030)
4.2.1 Global Standard Lancets Revenue by Type (2019-2024)
4.2.2 Global Standard Lancets Revenue by Type (2025-2030)
4.2.3 Global Standard Lancets Revenue Market Share by Type (2019-2030)
4.3 Global Standard Lancets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Standard Lancets Sales by Application (2019-2030)
5.1.1 Global Standard Lancets Sales by Application (2019-2024)
5.1.2 Global Standard Lancets Sales by Application (2025-2030)
5.1.3 Global Standard Lancets Sales Market Share by Application (2019-2030)
5.2 Global Standard Lancets Revenue by Application (2019-2030)
5.2.1 Global Standard Lancets Revenue by Application (2019-2024)
5.2.2 Global Standard Lancets Revenue by Application (2025-2030)
5.2.3 Global Standard Lancets Revenue Market Share by Application (2019-2030)
5.3 Global Standard Lancets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Standard Lancets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Standard Lancets Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Lifescan
6.2.1 Lifescan Corporation Information
6.2.2 Lifescan Description and Business Overview
6.2.3 Lifescan Standard Lancets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Lifescan Standard Lancets Product Portfolio
6.2.5 Lifescan Recent Developments/Updates
6.3 BD
6.3.1 BD Corporation Information
6.3.2 BD Description and Business Overview
6.3.3 BD Standard Lancets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BD Standard Lancets Product Portfolio
6.3.5 BD Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Standard Lancets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bayer Standard Lancets Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Abbott
6.5.1 Abbott Corporation Information
6.5.2 Abbott Description and Business Overview
6.5.3 Abbott Standard Lancets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Abbott Standard Lancets Product Portfolio
6.5.5 Abbott Recent Developments/Updates
6.6 B. Braun
6.6.1 B. Braun Corporation Information
6.6.2 B. Braun Description and Business Overview
6.6.3 B. Braun Standard Lancets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 B. Braun Standard Lancets Product Portfolio
6.6.5 B. Braun Recent Developments/Updates
6.7 ARKRAY
6.6.1 ARKRAY Corporation Information
6.6.2 ARKRAY Description and Business Overview
6.6.3 ARKRAY Standard Lancets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ARKRAY Standard Lancets Product Portfolio
6.7.5 ARKRAY Recent Developments/Updates
6.8 Terumo
6.8.1 Terumo Corporation Information
6.8.2 Terumo Description and Business Overview
6.8.3 Terumo Standard Lancets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Terumo Standard Lancets Product Portfolio
6.8.5 Terumo Recent Developments/Updates
6.9 I-SENS
6.9.1 I-SENS Corporation Information
6.9.2 I-SENS Description and Business Overview
6.9.3 I-SENS Standard Lancets Sales, Revenue and Gross Margin (2019-2024)
6.9.4 I-SENS Standard Lancets Product Portfolio
6.9.5 I-SENS Recent Developments/Updates
6.10 Nipro
6.10.1 Nipro Corporation Information
6.10.2 Nipro Description and Business Overview
6.10.3 Nipro Standard Lancets Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Nipro Standard Lancets Product Portfolio
6.10.5 Nipro Recent Developments/Updates
6.11 Omron
6.11.1 Omron Corporation Information
6.11.2 Omron Standard Lancets Description and Business Overview
6.11.3 Omron Standard Lancets Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Omron Standard Lancets Product Portfolio
6.11.5 Omron Recent Developments/Updates
6.12 Infopia
6.12.1 Infopia Corporation Information
6.12.2 Infopia Standard Lancets Description and Business Overview
6.12.3 Infopia Standard Lancets Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Infopia Standard Lancets Product Portfolio
6.12.5 Infopia Recent Developments/Updates
6.13 AgaMatrix
6.13.1 AgaMatrix Corporation Information
6.13.2 AgaMatrix Standard Lancets Description and Business Overview
6.13.3 AgaMatrix Standard Lancets Sales, Revenue and Gross Margin (2019-2024)
6.13.4 AgaMatrix Standard Lancets Product Portfolio
6.13.5 AgaMatrix Recent Developments/Updates
6.14 Smiths Medical
6.14.1 Smiths Medical Corporation Information
6.14.2 Smiths Medical Standard Lancets Description and Business Overview
6.14.3 Smiths Medical Standard Lancets Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Smiths Medical Standard Lancets Product Portfolio
6.14.5 Smiths Medical Recent Developments/Updates
6.15 Sarstedt
6.15.1 Sarstedt Corporation Information
6.15.2 Sarstedt Standard Lancets Description and Business Overview
6.15.3 Sarstedt Standard Lancets Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Sarstedt Standard Lancets Product Portfolio
6.15.5 Sarstedt Recent Developments/Updates
6.16 SANNUO
6.16.1 SANNUO Corporation Information
6.16.2 SANNUO Standard Lancets Description and Business Overview
6.16.3 SANNUO Standard Lancets Sales, Revenue and Gross Margin (2019-2024)
6.16.4 SANNUO Standard Lancets Product Portfolio
6.16.5 SANNUO Recent Developments/Updates
6.17 Yicheng
6.17.1 Yicheng Corporation Information
6.17.2 Yicheng Standard Lancets Description and Business Overview
6.17.3 Yicheng Standard Lancets Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Yicheng Standard Lancets Product Portfolio
6.17.5 Yicheng Recent Developments/Updates
6.18 Yuwell
6.18.1 Yuwell Corporation Information
6.18.2 Yuwell Standard Lancets Description and Business Overview
6.18.3 Yuwell Standard Lancets Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Yuwell Standard Lancets Product Portfolio
6.18.5 Yuwell Recent Developments/Updates
6.19 Greiner Bio One
6.19.1 Greiner Bio One Corporation Information
6.19.2 Greiner Bio One Standard Lancets Description and Business Overview
6.19.3 Greiner Bio One Standard Lancets Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Greiner Bio One Standard Lancets Product Portfolio
6.19.5 Greiner Bio One Recent Developments/Updates
6.20 Edan
6.20.1 Edan Corporation Information
6.20.2 Edan Standard Lancets Description and Business Overview
6.20.3 Edan Standard Lancets Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Edan Standard Lancets Product Portfolio
6.20.5 Edan Recent Developments/Updates
6.21 Narang Medical
6.21.1 Narang Medical Corporation Information
6.21.2 Narang Medical Standard Lancets Description and Business Overview
6.21.3 Narang Medical Standard Lancets Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Narang Medical Standard Lancets Product Portfolio
6.21.5 Narang Medical Recent Developments/Updates
6.22 Accu-Chek
6.22.1 Accu-Chek Corporation Information
6.22.2 Accu-Chek Standard Lancets Description and Business Overview
6.22.3 Accu-Chek Standard Lancets Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Accu-Chek Standard Lancets Product Portfolio
6.22.5 Accu-Chek Recent Developments/Updates
6.23 OneTouch
6.23.1 OneTouch Corporation Information
6.23.2 OneTouch Standard Lancets Description and Business Overview
6.23.3 OneTouch Standard Lancets Sales, Revenue and Gross Margin (2019-2024)
6.23.4 OneTouch Standard Lancets Product Portfolio
6.23.5 OneTouch Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Standard Lancets Industry Chain Analysis
7.2 Standard Lancets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Standard Lancets Production Mode & Process
7.4 Standard Lancets Sales and Marketing
7.4.1 Standard Lancets Sales Channels
7.4.2 Standard Lancets Distributors
7.5 Standard Lancets Customers
8 Standard Lancets Market Dynamics
8.1 Standard Lancets Industry Trends
8.2 Standard Lancets Market Drivers
8.3 Standard Lancets Market Challenges
8.4 Standard Lancets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock